Thursday, April 28, 2011

IMPACT OF GENERIC COMPETITION ON PHARMACEUTICAL PRODUCT SALES OR PRESCRIPTION VOLUME OF BRANDS IN THE US - GETTING MORE PAINFUL


In 2006, post 180 days exclusivity, pharmaceutical products could retain 50% of their sales, while in 2010 post 180 days exclusivity, pharmaceutical brand sales are just 20% of pre expiry sales level